Skip to main content
. Author manuscript; available in PMC: 2018 Apr 16.
Published in final edited form as: J Am Coll Surg. 2008 Mar 17;206(5):833–848. doi: 10.1016/j.jamcollsurg.2007.12.020

FIGURE 2.

FIGURE 2

Treatment of 160 patients with borderline resectable pancreatic cancer. All patients were received induction therapy; 125 (78%) patients completed therapy and returned for preoperative restaging. Surgery was recommended in 82 patients, of whom 79 underwent operation; 66 (41% of 160 total patients) were resected. Reasons for failure to receive all therapy included the development of disease progression and/or an irreversible decline in performance status.